THLD Financial Facts
Net loss: -5.7MLoss from operations: -5.24M
See Full Income Statement
Total current assets: 29.53M
Accumulated other comprehensive gain (loss): 2K
See Full Balance Sheet
Threshold Pharmaceuticals, Inc. (THLD) Earnings
|
Expand Research on THLD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/3/11 | Q311 | -$0.08 | -$0.15 | +$0.07 | N/A | N/A | N/A |  | | Details | |
| 5/3/12 | Q112 | -$2.12 | N/A | N/A | N/A | $15.65M | N/A | | | Details | |
| 11/2/12 | Q312 | -$0.06 | -$0.06 | $0.00 | $1.8M | $2.29M | N/A | | | Details | |
| 5/2/13 | Q113 | -$0.16 | -$0.09 | -$0.07 | $2.9M | $2.8M | N/A | | | Details | |
| 11/4/13 | Q313 | $0.02 | -$0.14 | +$0.16 | $3.2M | $3.15M | N/A | | | Details | |
| 3/6/14 | Q413 | -$0.13 | -$0.10 | -$0.03 | $3.2M | $3.58M | N/A | | | Details | |
| 11/3/14 | Q314 | -$0.15 | -$0.12 | -$0.03 | $3.7M | $3.82M | N/A | | | Details | |
| 3/3/15 | Q414 | -$0.12 | -$0.13 | +$0.01 | $3.7M | $4.1M | N/A | | | Details |
